Kp. Claffey et Gs. Robinson, REGULATION OF VEGF VPF EXPRESSION IN TUMOR-CELLS - CONSEQUENCES FOR TUMOR-GROWTH AND METASTASIS/, Cancer metastasis reviews, 15(2), 1996, pp. 165-176
Vascular endothelial growth factor (VEGF), also known as vascular perm
eability factor (VPF) is a multifunctional cytokine which potently sti
mulates angiogenesis in vivo. VEGF/VPF expression is elevated in patho
logical conditions including cancer, proliferative retinopathy, psoria
sis and rheumatoid arthritis. The angiogenesis associated with human t
umors is likely a central component in promoting tumor growth and meta
static potential. The regulation of VEGF/VPF expression during tumor p
rogression may involve diverse mechanisms including activated oncogene
s, mutant or deleted tumor suppressor genes, cytokine activation, horm
onal modulators, and a particularly effective activator, hypoxia. Unde
rstanding the diverse mechanisms by which tumor cells overexpress VEGF
/VPF and which mechanisms are operating in specific tumor types is imp
ortant for the design of effective anti-cancer therapies.